InvestorsHub Logo
Followers 138
Posts 22969
Boards Moderated 0
Alias Born 04/08/2004

Re: kevindenver post# 315743

Saturday, 06/19/2021 10:17:53 AM

Saturday, June 19, 2021 10:17:53 AM

Post# of 459796
Neuronetrix Has Been Selected By Anavex Life Sciences Corp. To Support The Upcoming Phase 2a Clinical Trial For ANAVEX 2-73

https://www.cognision.com/neuronetrix-has-been-selected-by-anavex-life-sciences-corp-to-support-the-upcoming-phase-2a-clinical-trial-for-anavex-2-73/

Dr. Marco Cecchi, Neuronetrix’s Director of Research and Clinical Affairs.

Crystalline form of ANAVEX2-73 for the treatment of Alzheimer's disease

Abstract
Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.

Inventors: Cecchi; Marco (Louisville, KY)
Applicant:
Name City State Country Type

Anavex Life Sciences Corp.
New York
NY
US
Assignee: ANAVEX LIFE SCIENCES CORP. (New York, NY)

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10,426,754.PN.&OS=PN/10,426,754&RS=PN/10,426,754

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News